Results 41 to 50 of about 6,357 (207)

Bench-to-bedside review: Erythropoietin and its derivatives as therapies in critical care [PDF]

, 2012
Author can archive publisher's pdf. Free via Creative Commons: CC-BENCHTOBEDSIDE-2.0.
Nandra, KK, Patel, NSA, Thiemermann, C
core   +1 more source

Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years' Experience Gained. [PDF]

, 2018
High-quality, safe, and effective biosimilars have the potential to increase access to biological therapies worldwide and to reduce cancer care costs.
Aapro, Matti, Gascón, Pere, Krendykov, Andriy, Schiestl, Martin   +3 more
core   +1 more source

Influence of hemoglobin level and dose of administered recombinant human beta erythropoietin on survival of hemodialysis patients [PDF]

, 2011
Background/Aim. In patients with end-stage renal disease, treatment with erythropoietin lowers cardiovascular morbidity, improves quality of life and patient survival.
Božić Dušan, Budošan Ivana, Knežević Violeta, Majić Milena, Milošević Aleksandra, Vodopivec Slavenka   +5 more
core   +1 more source

Multiple myeloma and physical activity: a scoping review [PDF]

, 2015
Objectives: Multiple myeloma is the second most common haematological cancer. A growing body of literature is emerging that investigates the role physical activity plays in all stages of multiple myeloma (prevention and survivorship) and to date no ...
Fisher, A, Heinrich, M, McCourt, O, Paton, B, Smith, L, Wardle, J, Yong, K   +6 more
core   +1 more source

Fatigue visual analogue scale score correlates with quality of life in cancer patients receiving epoetin alfa (Sandoz) for chemotherapy-induced anaemia: The CIROCO study

Cancer Treatment and Research Communications, 2023
Purpose: Available tools to measure fatigue and health-related quality of life (HRQoL) in cancer patients are often difficult to use in clinical practice. The fatigue visual analogue scale (VAS) provides a simple method to assess fatigue.
Jerome Desramé, Nathalie Baize, Amélie Anota, Kamel Laribi, Laetitia Stefani, Salim Hjiej, Ekatérina Nabirotchkina, Laurent Zelek, Sylvain Choquet   +8 more
doaj   +1 more source

Contemporary Practice of Anemia Treatment Among Dialysis Patients in the United States

Kidney International Reports, 2023
Introduction: The treatment of anemia is a major activity in the care of patients undergoing maintenance hemodialysis (HD). The comparative effectiveness of new pharmacologic treatments, relative to erythropoiesis-stimulating agents (ESAs), should be ...
Eric D. Weinhandl, William Eggert, Yunji Hwang, David T. Gilbertson, Jeffrey Petersen   +4 more
doaj   +1 more source

PSY34 Economic Evaluation of Ferinject in the Treatment of Anemia Patients in the Greek Hospital Setting: a Cost Minimization Analysis [PDF]

, 1880
Von ...
Fragoulakis, V., Kourlaba, G., Goumenos, D., Konstantoulakis, M., Maniadakis, N.   +4 more
core   +1 more source

Amyloid β Instigates Cardiac Neurotrophic Signaling Impairment, Driving Alzheimer's Associated Heart Disease

Advanced Science, EarlyView.
This research identified cardiac amyloid pathology, neurotrophic factor depletion, and reduced myocardial nerve function in a transgenic model of cerebral amyloidosis (Tg2576), Aβ‐challenged cardiomyocytes, and in human AD heart tissue. These findings carry significant diagnostic and therapeutic implications, emphasizing the role of neuro‐signaling ...
Andrea Elia, Rebecca Parodi‐Rullan, Rafael Vazquez‐Torres, Ashley Carey, Huaqing Zhao, Sabzali Javadov, Silvia Fossati   +6 more
wiley   +1 more source

Correction of anemia in multiple myeloma patients by erythropoiesis-stimulating agents

Онкогематология, 2014
In this paper analysis of anemia correction efficacy in multiple myeloma patients was shown. Patients (n = 68) treated with epoetin alfa (recombinant erythropoietin (rEPO)) 150 IU/kg subcutaneously three times per week (no more 20 weeks) were included in
N. A. Romanenko, N. A. Potikhonova, K. M. Abdulkadyrov   +2 more
doaj   +3 more sources

The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data

BMC Nephrology, 2009
Background In patients treated by maintenance hemodialysis the relationship to survival of hemoglobin level and administered epoetin-alfa and intravenous iron is controversial.
Shukla Rakesh, Lorch Jonathan A, Pollak Victor E, Satwah Supriya   +3 more
doaj   +1 more source